Keyphrases
HIV-associated Neurocognitive Disorders
100%
Anti-neuroinflammation
100%
Potential Therapy
100%
Combined Antiretroviral Therapy (cART)
60%
Viral Load
20%
Inflammatory Cytokines
20%
HIV Patients
20%
Pathogenic Process
20%
Chemokines
20%
Immune Activation
20%
Potential Therapeutics
20%
HIV+
20%
Glutamate
20%
Pathologic Processes
20%
Minocycline
20%
Viral Glycoprotein
20%
Neuroprotective Properties
20%
Therapeutic Avenues
20%
Teriflunomide
20%
Dimethyl Fumarate
20%
Increasing Life Expectancy
20%
Immunomodulatory Properties
20%
Long-term Suppression
20%
HIV-associated Dementia
20%
Reactive Oxygen Metabolites
20%
Medicine and Dentistry
HIV-associated Neurocognitive Disorder
100%
Antiretroviral Therapy
50%
Human Immunodeficiency Virus
33%
Drug Therapy
16%
Prevalence
16%
Cytokine
16%
Metabolite
16%
Chemokine
16%
Life Expectancy
16%
Physical Disease by Body Function
16%
Immunity
16%
Neuroprotective Agent
16%
Glutamic Acid
16%
Minocycline
16%
Reactive Oxygen Species
16%
Human Immunodeficiency Virus Protein
16%
Teriflunomide
16%
Fumaric Acid Dimethyl Ester
16%
Pharmacology, Toxicology and Pharmaceutical Science
HIV Associated Dementia
100%
HIV
33%
Prevalence
16%
Reactive Oxygen Metabolite
16%
Cytokine
16%
Chemokine
16%
Physical Disease by Body Function
16%
Life Expectancy
16%
Glutamic Acid
16%
Neuroprotective Agent
16%
Minocycline
16%
Human Immunodeficiency Virus Protein
16%
Fumaric Acid Dimethyl Ester
16%
Teriflunomide
16%
Neuroscience
HIV Associated Dementia
100%
Human Immunodeficiency Virus
33%
Proinflammatory Cytokine
16%
Chemokine
16%
Neuroprotective Agent
16%
Glutamic Acid
16%
Minocycline
16%
Human Immunodeficiency Virus Protein
16%
Teriflunomide
16%